Ping An Biomedical Co. Class APASW

13F holders, Q1 2026 (March 31)
4holders +1
2new positions
1sold out
$0.13avg. 13F price*

At the end of Q1 2026, 4 institutions reported holding Ping An Biomedical Co. Class A (PASW) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were XTX Topco Ltd ($18K), Jane Street Group, LLC ($7K) and Two Sigma Securities, LLC ($4K).

Company
Ping An Biomedical Co. Class A
CUSIP
G5880S105
Latest filing quarter
Q1 2026

History

Number of 13F holders

01234 Q3 2025: 3Q3 2025Q4 2025: 3Q4 2025Q1 2026: 4Q1 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$11K
Exits1$11K

All 13F filers, Q4 2025 → Q1 2026: 210,604 shares bought and 22,886 shares sold, net +187,718 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

XTX Topco Ltd 0.00% Add +491.1% 136,427 $18K
Jane Street Group, LLC 0.00% New 52,518 $7K
Two Sigma Securities, LLC 0.00% New 33,223 $4K
UBS Group AG 0.00% Add +243.8% 16,239 $2K

"% of holder's portfolio" is PASW's weight in each manager's 13F, not the share of Ping An Biomedical Co. Class A the manager owns.